Delivering pharmaceuticals safely

Upcoming events:

Extractables and Leachables Europe 2014

Smithers Rapra is pleased to announce the 8th annual Extractables and Leachables European conference has been confirmed. Due to the huge success and growth E&L Europe has had over the last couple of years, the conference this year is proud to stand alone, with even more dedicated networking time in a dedicated environment.

Extractables and Leachables Europe 2014 will be coming to Barcelona on 10-12 November 2014 at the Novotel Barcelona City, Spain.

Book your place to attend the 2014 Extractables and Leachables pre-conference workshop and two day conference >>

The agenda is now finalised, with representatives from MHRA, Baxter, Janssen Biologics, Roche and Gerresheimer confirmed, don't miss out - view the full programme now >>

Stay connected and hear all of the latest E&L news

twitter LinkedIn

Download the E&L Conference brochure >>


Past events:

E&L USA 2014

E&L USA 2014 was held from May 7-9 at the Sheraton Silver Spring, MD. It was a great success with over 18 expert speakers from companies including Boehringer Ingelheim, NovoNordisk and Baxter, As well as an opening address from Dr Ingrid Markovic of the FDA.

The delegate attendance broke last year's record, attracting over 100 attendees who provided great feedback for the Extractables & Leachables USA 2014 conference:

100% were likely to attend again
100%
rated the overall conference experience as excellent or above average
100%
of workshop attendees would recommend to a colleague

Watch this space for the 2015 event to be announced

Find out more about the Extractable and Leachables USA 2014 conference >>

E&L USA 2013

Run by Smithers Rapra, in Providence, RI in May 2013, the US forum provided delegates with the opportunity to come together to discuss all of the current E&L issues facing the pharmaceutical industry.

With 100% postitive delegate feedback and more than half of attendees expecting to generate new business from the conference, this event was a great success with a huge audience beating last yea'rs record attendance.

This inaugural event featured a high profile line up of speakers from working groups IPAC-RS, PQRI, ELSIE and industry leaders Boehringer Ingelheim, Eli Lilly, NovoNordisk, and many more!

speaking companies

See more about E&L USA >>

E&L Europe 2013

eandlWith the largest audience to date the 2013 Extractables and Leachables Europe was one of the biggest and best conferences to date. With attendees providing great feedback...

- 100% will definitely or are likely to attend again
- 100% rated the overall conference experience as excellent or above average
- 98% said the speakers were excellent or above average
- 98% found the content was excellent or above average

On 10-11 December, the conference programme featured a comprehensive representation of best practice examples in pharmaceutical packaging, as well as the latest regulatory and working group updates, analytical chemist perspectives, and technical innovations from top pharmaceutical companies and materials suppliers.

Not only did delegates hear from many top speakers including experts from GlaxoSmithKline, Borealis Group, Baxter Innovations and more, they also had the chance to network with industry peers and potential clients throughout their time in London.

See who you missed in London >>


Conference proceedings

The conference proceedings will be available for purchase through the Smithers Rapra website, 8 weeks after the conference. They contain the papers presented by speakers over the two-day event.

Supporting Partner

Medical News Banner

Stay up to date with industry developments on Linked In Arrows

Stay up to date with industry developments on Linked In

Join the Smithers Rapra Extractables and Leachables LinkedIn group to share and discuss ideas about the analysis of extractables and leachables in medical devices...view link

E&L EU Key Speakers

Dennis Jenke
Baxter Healthcare Corp

Dr. Dennis Jenke is a Baxter Distinguished Scientist in the Technology Resources Division of the Baxter Healthcare Corporation. In this role, he works with a team of analytical chemistry professionals whose primary responsibility includes the development, validation and application of diverse analytical strategies and methods for the discovery, identification and quantification of trace constituents in pharmaceutically relevant solutions and samples.

Dennis Jenke
Aidan Sexton
Janssen Biologics

Aidan Sexton is an Industrial Chemist with a doctorate in Physical Chemistry. He has 25 years of experience in R&D and pharmaceutical manufacturing with several multinationals including Pfizer, Janssen and Antigen. Aidan has held a number of senior roles in the areas of Process Development, Validation, Quality Assurance and Engineering. These roles have been in biopharmaceutical, sterile fill finish and API manufacturing organisations. Currently, he works in a Technical Operations role in Janssen Biologics, Cork and is the site SME for extractables & leachables.

Aidan Sexton
Juergen Wilhelm
Roche Diagnostics GmbH

In 2003 Juergen reached the degree Dipl.-Ing. (FH) at the Georg-Simon-Ohm University of Applied Science in “technical chemistry”. In 2004 he joined Roche Diagnostics in Penzberg at the department of quality control raw materials and since 2007 his work is focused on single used raw materials (plastics and glass). and he is a member of the Leachables and Extractables Team in Penzberg.

Juergen Wilhelm
Alan Hendricker
Becton Dickinson

Dr. Alan Hendricker has 15 years of experience in extractables and leachables analysis and 25 years of experience with mass spectrometry. He received his undergraduate degree from Ohio University and Ph.D. from the Colorado School of Mines in 1999. He was a co-author on the PQRI Working Group on Leachables and Extractables recommendation “Safety Thresholds and Best Practices for Leachables and Extractables in Orally Inhaled and Nasal Drug Products (OINDPs).” He has been an active member of the PQRI Leachables and Extractables Parenteral Ophthalmic Drug Product (PODP) working group. He has written and presented extensively on extractables and leachables issues. Alan has been a member of the Structural Chemistry Group at Magellan Laboratories through its acquisitions by Cardinal Health and subsequent purchase by the Blackstone Group as Catalent Pharma Solutions. Since January of 2014, Alan works at Becton Dickinson (BD) as part of the corporate preclinical development group on extractables and leachables studies for BD devices and products.

Alan Hendricker
Stay in touch
icon

Sign up to receive further information and event updates.

Sponsors and Exhibitors
  • bibra toxicology advice & consulting
  • GERSTEL Inc
  • NSF Health Sciences
  • RC Pharma
  • SGS Life Science Services
  • Smithers Rapra
  • Toxikon Europe NV
Media Partners
  • pharmaphorum
  • Medical News Today
  • Eurasian Chemical Market